Novel aldose reductase inhibitors derived from 6-[[(diphenylmethylene) amino]oxy]hexanoic acid

Archiv der Pharmazie

Volumn 340, Issue 4, 2007, Pages 202-208

  Rakowitz, Dietmar ^a   Piccolruaz, Grete ^a   Pirker, Cornelia ^a   Matuszczak, Barbara ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

6 (Diphenylmethylene)amino oxy hexanoic acids; Aldose reductase inhibitors; Benzophenone oxime congeners; SAR

Indexed keywords

6 [[(DIPHENYLMETHYLENE)AMINO]OXY]HEXANOIC ACID; ALDOSE REDUCTASE INHIBITOR; BENZENE DERIVATIVE; CARBENE; FLUORENONE DERIVATIVE; HEXANOIC ACID; PYRIDINE; THIOPHENE; THIOXANTHENE DERIVATIVE; UNCLASSIFIED DRUG; XANTHONE 4 ACETIC ACID; ALDEHYDE REDUCTASE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ENZYME INHIBITOR; HEXANOIC ACID DERIVATIVE; OXIME;

ARTICLE; DRUG STRUCTURE; PRIORITY JOURNAL; ALKYLATION; ANIMAL; CATTLE; DRUG ANTAGONISM; INFRARED SPECTROPHOTOMETRY; KINETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; SOLUBILITY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ALDEHYDE REDUCTASE; ALKYLATION; ANIMALS; CATTLE; CHEMISTRY, PHYSICAL; ENZYME INHIBITORS; HEXANOIC ACIDS; INDICATORS AND REAGENTS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; OXIMES; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34250847580     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200600166     Document Type: Article

References (27)

1. http://www.who.int/mediacentre/factsheets/fs138/en/.
2. M. Brownlee, Nature 2001, 414, 813-820.
3. S. Miyamoto, Exp. Opin. Ther. Patents 2002, 12, 621-631.
4. S. Suzen, E. Buyukbingol, Curr. Med. Chem. 2003, 10, 1329-1352.
5. M. C. Van Zandt, M. L. Jones, D. E. Gunn, L. S. Geraci, et al., J. Med. Chem. 2005, 48, 3141-3152.
6. B. L. Mylari, S. J. Armento, D. A. Beebe, E. L. Conn, et al., J. Med. Chem. 2005, 48, 6326-6339.
7. F. Da Settimo, G. Primofiore, C. La Motta, S. Sartini, et al., J. Med. Chem. 2005, 48, 6897-6907.
8. D. Rakowitz, G. Heinisch, P. Lukavsky, S. Kiendler, et al., J. Heterocycl. Chem. 2000, 37, 1089-1096.
9. D. Rakowitz, B. Matuszczak, S. Gritsch, P. Hofbauer, et al., Eur. J. Pharm. Sci. 2002, 15, 11-20.
10. R. Maccari, R Ottanà, C. Curinga, M. G. Vigorita, et al., Bioorg. Med. Chem. 2005, 13, 2809-2823.
11. D. Rakowitz, B. Hennig, M. Nagano, S. Steger, et al., Arch. Pharm. Chem. Life Sci. 2005, 338, 411-418.
12. D. Rakowitz, P. Muigg, N. Schröder, B. Matuszczak, Arch. Pharm. Chem. Life Sci. 2005, 338, 419-426.
13. D. Rakowitz, A. Gmeiner, N. Schröder, B. Matuszczak, Eur. J. Pharm. Sci. 2006, 27, 188-193.
14. D. Rakowitz, R. Maccari, R. Ottanà, M. G. Vigorita, Bioorg. Med. Chem. 2006, 14, 567-574.
15. A. Pau, B. Asproni, G. Murineddu, G. Boatto, et al., Med. Chem. 2006, 2, 39-45.
16. D. Rakowitz, H. Angerer, B. Matuszczak, Arch. Pharm. Chem. Life Sci. 2006, 339, 547-558.
17. D. Rakowitz, A. Gmeiner, B. Matuszczak, Arch. Pharm. Chem. Life Sci. 2006, 339, 559-563.
18. E. I. Howard, R. Sanishvili, R. E. Cachau, A. Mitschler, et al., Proteins 2004, 55, 792-804.
19. O. El-Kabbani, C. Darmanin, T. R. Schneider, I. Hazemann, et al., Proteins 2004, 55, 805-813.
20. T. Kinoshita, H. Miyake, T. Fujii, S. Takakura, T. Goto, Acta Cryst. 2002, D58, 622-626.
21. A. Podjarny, R. E. Cachau, T. Schneider, M. van Zandt, A. Joachimiak, Cell. Mol. Life Sci. 2004, 61, 763-773.
22. A. Urzhumtsev, F. Tete-Favier, A. Mitschler, J. Barbanton, et al., Structure 1997, 5, 601-612.
23. D. K. Wilson, I. Tarle, J. M. Petrash, F. A. Quiocho, Proc. Natl. Acad. Sci. USA 1993, 90, 9847-9851.
24. B. Barth, M. Dierich, G. Heinisch, V. Jenny, et al., Antiviral Chem. Chemother. 1996, 7, 300-312.
25. G. Heinisch, W. Holzer, T. Langer, P. Lukavsky, Heterocycles 1996, 43, 151-172.
26. E. Abele, R. Abele, K. Rubina, J. Popelis, et al., Synth. Commun. 1998, 28, 2621-2633.
27. T.-C. Chou, M. P. Hayball, 1996 CalcuSyn software version 1.1.1., Biosoft, Cambridge, UK.